Sanofi SA

54, Rue La Boétie,
Paris, 75008
France,
+33 1 53 77 40 00
www.sanofi.com

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales.

M&A Summary

Buy vs Sell

Year ≤ '12 '13 '14 '15 '16 '17 T
Buy (0.2/yr) # 17 1 - - - - 18
vol $29.1B $29.1B
Sell (0.6/yr) # 2 - - - 1 2 5
vol $425M $94M $519M
  23

Top M&A Advisors

Financial Deals
Sign-up to View
1
Sign-up to View
1
Legal Deals
Sign-up to View
1
Sign-up to View
1

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Genzyme Corp.
$20.1B (2011-02-16)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View
Largest Dermik Laboratories, Inc.
$425M (2011-07-11)

According to our data here at Mergr, Sanofi SA has acquired 20 companies, including 1 in the last 5 years. A total of 7 acquisitions came from private equity firms. It has also divested 5 assets.

Sanofi SA’s largest acquisition to date was in 2011, when it acquired Genzyme for $20.1B. It’s largest disclosed sale occurred in 2011, when it sold Dermik Laboratories to Valeant Pharmaceuticals International for $425M. Sanofi SA has acquired in 8 different US states, and 8 countries. The Company’s most targeted sectors include life science (50%) and medical products (23%).

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 415 life science companies that have made at least 1 acquisition, 25 have acquired at least 5 companies, and 3 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 24 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 4 platform acquisitions.

Join Mergr and gain access to Sanofi SA’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.3K Private Equity Firms
  • 111K M&A Transactions
  • 121K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.